| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/22/2014 | US8703908 Expression and export of angiogenesis inhibitors as immunofusins |
| 04/22/2014 | US8703906 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
| 04/22/2014 | US8703905 Endoplasmic reticulum localization signals |
| 04/22/2014 | US8703903 Method for quantification of allergens |
| 04/22/2014 | US8703722 Inhibitors of F18+ E coli binding |
| 04/22/2014 | US8703718 Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule |
| 04/22/2014 | US8703710 Method of reducing cell death by administering a paracrine factor of a mesenchymal stem cell |
| 04/22/2014 | US8703706 Closed container comprising an activated factor VII polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 04/22/2014 | US8703705 Modified factor VIII peptides |
| 04/22/2014 | US8703702 Therapeutically active α-MSH analogues |
| 04/22/2014 | US8703699 Lactoferrin |
| 04/22/2014 | US8703698 Compositions and methods for treating atherosclerosis |
| 04/22/2014 | US8703693 Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment |
| 04/22/2014 | US8703503 Methods and compositions for inhibition of BCL6 repression |
| 04/22/2014 | US8703468 Porcine circovirus type 2B isolate and uses thereof |
| 04/22/2014 | US8703436 Identification of Porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 04/22/2014 | US8703431 Polypeptides for the in vitro assessment of the sensitising potential of a test compound |
| 04/22/2014 | US8703150 Methods of using Bacillus anthracis protective antigen sequences for vaccination |
| 04/22/2014 | US8703146 Toll-like receptor 5 ligands and methods of use |
| 04/22/2014 | US8703145 Materials and methods for immunizing against FIV infection |
| 04/22/2014 | US8703144 Allergen peptide fragments and use thereof for treatment of dust mite allergies |
| 04/22/2014 | US8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses |
| 04/22/2014 | US8703098 Labelled adrenomedullin derivatives and their use for imaging and therapy |
| 04/22/2014 | CA2751655C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 04/22/2014 | CA2704532C Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate |
| 04/22/2014 | CA2658949C Inhibition of marcks-mediated degranulation by marcks n-terminal pepetides in treating inflammation |
| 04/22/2014 | CA2658677C Novel bacillus thuringiensis gene with lepidopteran activity |
| 04/22/2014 | CA2642654C Process for preparing human g-csf |
| 04/22/2014 | CA2580713C Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability |
| 04/22/2014 | CA2580620C Method of detecting hepatitis b virus s antigen |
| 04/22/2014 | CA2572015C Fc-interferon-beta fusion proteins |
| 04/22/2014 | CA2561530C Therapeutic or prophylactic agent for arthritis |
| 04/22/2014 | CA2548135C Synthetic hla binding peptide analogues and uses thereof |
| 04/22/2014 | CA2546287C Reduction of dermal scarring |
| 04/22/2014 | CA2507817C Il-21 production in prokaryotic hosts |
| 04/22/2014 | CA2507307C Increased production of secg protein in bacillus subtilis |
| 04/22/2014 | CA2469785C Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 04/22/2014 | CA2394357C Modified leukotoxin gene and protein |
| 04/22/2014 | CA2333921C Verotoxin b subunit for immunization |
| 04/17/2014 | WO2014059336A1 Exosomes and diagnostic biomarkers |
| 04/17/2014 | WO2014059296A1 An attenuated ehec and clostridial toxins tcda and tcdb based vaccine for clostridium difficil associated disease (cdad) |
| 04/17/2014 | WO2014059255A1 Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins |
| 04/17/2014 | WO2014059154A1 Genetically encoded calcium indicators and methods of use |
| 04/17/2014 | WO2014058985A1 High-throughput assays for enzyme inhibitors and peptide inhibitors against hiv-1 and methods for using them |
| 04/17/2014 | WO2014058830A1 Proteolytic inactivation of select proteins in bacterial extracts for improved expression |
| 04/17/2014 | WO2014057997A1 Reprogramming peptide and use thereof |
| 04/17/2014 | WO2014057528A1 Method for detecting squamous cell carcinoma |
| 04/17/2014 | WO2014057437A2 Method for preparing c1q recombinant protein |
| 04/17/2014 | WO2014057436A2 Anticancer conjugate |
| 04/17/2014 | WO2014057134A1 Csn5 polypeptides and uses thereof for screening therapeutic agents |
| 04/17/2014 | WO2014057045A1 Methods and pharmaceutical compositions for treatment of gastrointestinal stromal tumors |
| 04/17/2014 | WO2014057044A1 Cdkact biosensors-fluorescent polypeptide to probe the activity of cdk/cyclin kinases in vitro, in cellulo and in vivo |
| 04/17/2014 | WO2014056885A1 Cooperia vaccine |
| 04/17/2014 | WO2014056872A1 Exendin-4 derivatives as dual glp1/glucagon agonists |
| 04/17/2014 | WO2014056813A1 Cell penetrating peptides which bind irf5 |
| 04/17/2014 | WO2014056422A1 hnRNP A2* PROTEIN, NUCLEIC ACID FOR CODING PROTEIN AND USE THEREOF |
| 04/17/2014 | WO2014056333A1 Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor |
| 04/17/2014 | WO2014056199A1 Production and purification methods of polypeptide |
| 04/17/2014 | WO2014056026A1 Improved process for purifying growth factors from milk and products thereof |
| 04/17/2014 | WO2014056025A1 Improved process for purifying lactoferrin from milk and products thereof |
| 04/17/2014 | WO2014033540A3 Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods of making and using thereof |
| 04/17/2014 | WO2014030097A3 Solid dishwashing detergent with improved protease performance |
| 04/17/2014 | WO2014030096A3 Genes and processes for the production of clavine-type alkaloids |
| 04/17/2014 | WO2014028773A3 Lignin degrading enzymes from macrophomina phaseolina and uses thereof |
| 04/17/2014 | WO2014020205A3 Improved anti-hiv immunogens |
| 04/17/2014 | WO2014006025A3 Marker of pathogenicity in salmonella |
| 04/17/2014 | WO2013158818A3 Vaccines and methods to treat lyme disease in dogs |
| 04/17/2014 | WO2013063556A8 Humanized il-6 and il-6 receptor |
| 04/17/2014 | WO2012119103A3 Compositions and methods for mobilization of stem cells |
| 04/17/2014 | WO2012106725A3 Methods and compositions for treating occular disorders |
| 04/17/2014 | US20140107324 Growth Hormones with Prolonged In-Vivo Efficacy |
| 04/17/2014 | US20140107322 Methods of use of soluble cd24 for therapy of rheumatoid arthritis |
| 04/17/2014 | US20140107315 Protein for affinity-separation matrix |
| 04/17/2014 | US20140107189 Modified polynucleotides encoding apoptosis inducing factor 1 |
| 04/17/2014 | US20140107041 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 04/17/2014 | US20140107036 Production and Delivery of a Stable Collagen |
| 04/17/2014 | US20140107034 Soluble hybrid fcgamma receptors and related methods |
| 04/17/2014 | US20140107023 Non-peptidyl polymer-insulin multimer and method for producing the same |
| 04/17/2014 | US20140107022 Chimeric fibroblast growth factor 19 proteins and methods of use |
| 04/17/2014 | US20140107021 Glucagon antagonist-gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity |
| 04/17/2014 | US20140107020 Fibronectin based scaffold domain proteins that bind to myostatin |
| 04/17/2014 | US20140107019 Engineered polypeptides having enhanced duration of action |
| 04/17/2014 | US20140107014 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2) |
| 04/17/2014 | US20140106405 Mammalian cell culture processes for protein production |
| 04/17/2014 | US20140106401 Selection of host cells expressing protein at high levels |
| 04/17/2014 | US20140106399 Methods for production and purification of polypeptides |
| 04/17/2014 | US20140106392 Method for generating cyan fluorescent proteins with reducd ph sensitivity |
| 04/17/2014 | US20140106371 Peptide Analogues of PA-IL and Their Utility for Glycan and Glycoconjugate Analysis and Purification |
| 04/17/2014 | US20140106365 Multiprotein assemblies |
| 04/17/2014 | US20140106341 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/17/2014 | US20140105964 Modified polynucleotides encoding aquaporin-5 |
| 04/17/2014 | US20140105931 Hepatitis c virus particles, vaccines, compositions and methods related thereto |
| 04/17/2014 | US20140105925 Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of Dengue Virus Infection |
| 04/17/2014 | US20140105906 Peptide for Protection of Allergic Respiratory Disorders |
| 04/17/2014 | US20140105903 Modulators of Plexin B2 Activity |
| 04/17/2014 | US20140105896 Fibronectin based scaffold domain proteins that bind to myostatin |
| 04/17/2014 | US20140105860 Engineered antibody-tnfsf member ligand fusion molecules |
| 04/17/2014 | US20140105856 System and Method for Collagen Isolation |
| 04/17/2014 | US20140105855 Structural based design of il-17 dominant negative mutants |
| 04/17/2014 | US20140105854 Vaccine for treatment and prevention of herpes simplex virus infection |